The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: Finding ways for prevention
Open accessAbstract
The world's population aging progression renders age‐related neurodegenerative diseases to be one of the biggest unsolved problems of modern society. Despite the progress in studying the development of pathology, finding ways for modifying neurodegenerative disorders remains a high priority. One common feature of neurodegenerative diseases is mitochondrial dysfunction and overproduction of reactive oxygen species, resulting in oxidative stress. Although lipid peroxidation is one of the markers for oxidative stress, it also plays an important role in cell physiology, including activation of phospholipases and stimulation of signaling cascades. Excessive lipid peroxidation is a hallmark for most neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and many other neurological conditions. The products of lipid peroxidation have been shown to be the trigger for necrotic, apoptotic, and more specifically for oxidative stress‐related, that is, ferroptosis and neuronal cell death. Here we discuss the involvement of lipid peroxidation in the mechanism of neuronal loss and some novel therapeutic directions to oppose it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ikram, M., Saeed, K., Khan, A., Muhammad, T., Khan, M., Jo, M., Rehman, S., & Kim, M. (2019) · Nutrients · doi:10.3390/nu11051082 · Cited by 97
RetractedChemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Oxygen toxicity, oxygen radicals, transition metals and disease
Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis
Kagan, V. E., Mao, G., Qu, F., Angeli, J. P. F., Doll, S., Croix, C. S., Dar, H. H., Liu, B., Tyurin, V. A., Ritov, V. B., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2238 · Cited by 3,029
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
Dodson, M., Castro-Portuguez, R., & Zhang, D. D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101107 · Cited by 2,435
Health effects of quercetin: From antioxidant to nutraceutical
Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121
Free Radical Lipid Peroxidation: Mechanisms and Analysis
Yin, H., Xu, L., & Porter, N. A. (2011) · Chemical Reviews · doi:10.1021/cr200084z · Cited by 1,937
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851
Lipid peroxidation in cell death
Gaschler, M. M., & Stockwell, B. R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.086 · Cited by 1,828
Singh, B. N., Shankar, S., & Srivastava, R. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.093 · Cited by 1,602
Eicosanoid storm in infection and inflammation
Dennis, E. A., & Norris, P. C. (2015) · Nature Reviews Immunology · doi:10.1038/nri3859 · Cited by 1,517
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A.-L., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,438
DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043
Mechanism of Oxidative Stress in Neurodegeneration
Gandhi, S., & Abramov, A. Y. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/428010 · Cited by 960
Self-citationHämäläinen, M., Nieminen, R., Vuorela, P., Heinonen, M., & Moilanen, E. (2007) · Mediators of Inflammation · doi:10.1155/2007/45673 · Cited by 944
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
Targeting Multiple Signaling Pathways by Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate
Khan, N., Afaq, F., Saleem, M., Ahmad, N., & Mukhtar, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3636 · Cited by 820
Targeting Huntingtin Expression in Patients with Huntington’s Disease
Tabrizi, S. J., Leavitt, B. R., Landwehrmeyer, G. B., Wild, E. J., Saft, C., Barker, R. A., Blair, N. F., Craufurd, D., Priller, J., Rickards, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900907 · Cited by 708
Abramov, A. Y., Scorziello, A., & Duchen, M. R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4468-06.2007 · Cited by 685
Self-citationMarks, W. J., Bartus, R. T., Siffert, J., Davis, C. S., Lozano, A., Boulis, N., Vitek, J., Stacy, M., Turner, D., Verhagen, L., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70254-4 · Cited by 684
LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70039-4 · Cited by 681
Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644
Wu, D.-C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937239100 · Cited by 633
Miller, T. M., Pestronk, A., David, W., Rothstein, J., Simpson, E., Appel, S. H., Andres, P. L., Mahoney, K., Allred, P., Alexander, K., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70061-9 · Cited by 617
Nrf2 regulates ROS production by mitochondria and NADPH oxidase
Kovac, S., Angelova, P. R., Holmström, K. M., Zhang, Y., Dinkova-Kostova, A. T., & Abramov, A. Y. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.021 · Cited by 604
Self-citationAbramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4042-03.2004 · Cited by 587
Self-citationTherapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., et al. (2017) · Nature · doi:10.1038/nature22038 · Cited by 571
Janssen, C. I. F., & Kiliaan, A. J. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.10.002 · Cited by 514
Ludtmann, M. H. R., Angelova, P. R., Horrocks, M. H., Choi, M. L., Rodrigues, M., Baev, A. Y., Berezhnov, A. V., Yao, Z., Little, D., Banushi, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04422-2 · Cited by 513
Self-citationMechanism of Coupling of Oxidative Phosphorylation and the Membrane Potential of Mitochondria
LIBERMAN, E. A., TOPALY, V. P., TSOFINA, L. M., JASAITIS, A. A., & SKULACHEV, V. P. (1969) · Nature · doi:10.1038/2221076a0 · Cited by 489
Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies
Epstein, J., Sanderson, I. R., & MacDonald, T. T. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509993667 · Cited by 464
Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro
Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08858.x · Cited by 463
Curcuminoids as Potent Inhibitors of Lipid Peroxidation
Sreejayan, & Rao, M. N. A. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03258.x · Cited by 459
Hong, J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh165 · Cited by 432
Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology
Ayton, S., Wang, Y., Diouf, I., Schneider, J. A., Brockman, J., Morris, M. C., & Bush, A. I. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0375-7 · Cited by 365
Deas, E., Cremades, N., Angelova, P. R., Ludtmann, M. H. R., Yao, Z., Chen, S., Horrocks, M. H., Banushi, B., Little, D., Devine, M. J., et al. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6343 · Cited by 360
Self-citationA phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson’s disease
Muramatsu, S.-I., Fujimoto, K.-I., Kato, S., Mizukami, H., Asari, S., Ikeguchi, K., Kawakami, T., Urabe, M., Kume, A., Sato, T., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.135 · Cited by 344
Caffeine as an Antioxidant: Inhibition of Lipid Peroxidation Induced by Reactive Oxygen Species
Devasagayam, T. P. A., Kamat, J. P., Mohan, H., & Kesavan, P. C. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(96)00040-5 · Cited by 331
Kim, C.-S., Kawada, T., Kim, B.-S., Han, I.-S., Choe, S.-Y., Kurata, T., & Yu, R. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00086-4 · Cited by 328
Jazwa, A., Rojo, A. I., Innamorato, N. G., Hesse, M., Fernández-Ruiz, J., & Cuadrado, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3731 · Cited by 327
Cell signalling by reactive lipid species: new concepts and molecular mechanisms
Higdon, A., Diers, A. R., Oh, J. Y., Landar, A., & Darley-Usmar, V. M. (2012) · Biochemical Journal · doi:10.1042/bj20111752 · Cited by 317
Zhang, Y.-H., Wang, D.-W., Xu, S.-F., Zhang, S., Fan, Y.-G., Yang, Y.-Y., Guo, S.-Q., Wang, S., Guo, T., Wang, Z.-Y., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.001 · Cited by 304
Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2
Laneuville, O., Breuer, D. K., Xu, N., Huang, Z. H., Gage, D. A., Watson, J. T., Lagarde, M., DeWitt, D. L., & Smith, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19330 · Cited by 301
Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
Bomprezzi, R. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285614564152 · Cited by 301
Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation
Angelova, P. R., Choi, M. L., Berezhnov, A. V., Horrocks, M. H., Hughes, C. D., De, S., Rodrigues, M., Yapom, R., Little, D., Dolt, K. S., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0542-z · Cited by 296
Self-citationReinisalo, M., Kårlund, A., Koskela, A., Kaarniranta, K., & Karjalainen, R. O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/340520 · Cited by 284
Smith, A., Giunta, B., Bickford, P. C., Fountain, M., Tan, J., & Shytle, R. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.012 · Cited by 280
Functional Oxygen Sensitivity of Astrocytes
Angelova, P. R., Kasymov, V., Christie, I., Sheikhbahaei, S., Turovsky, E., Marina, N., Korsak, A., Zwicker, J., Teschemacher, A. G., Ackland, G. L., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0045-15.2015 · Cited by 279
Self-citationIron and Alzheimer’s Disease: An Update on Emerging Mechanisms
Lane, D. J. R., Ayton, S., & Bush, A. I. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179944 · Cited by 276
Functional role of mitochondrial reactive oxygen species in physiology
Angelova, P. R., & Abramov, A. Y. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.005 · Cited by 267
Self-citationA mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria
Trnka, J., Blaikie, F. H., Smith, R. A. J., & Murphy, M. P. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.036 · Cited by 265
Pérez-Torres, I., Guarner-Lans, V., & Rubio-Ruiz, M. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102098 · Cited by 252
Lipid Peroxidation and Free Radical Scavengers in Alzheimer’s Disease
Jeandel, C., Nicolas, M. B., Dubois, F., Nabet-Belleville, F., Penin, F., & Cuny, G. (1989) · Gerontology · doi:10.1159/000213037 · Cited by 250
Nrf2 affects the efficiency of mitochondrial fatty acid oxidation
Ludtmann, M. H. R., Angelova, P. R., Zhang, Y., Abramov, A. Y., & Dinkova-Kostova, A. T. (2014) · Biochemical Journal · doi:10.1042/bj20130863 · Cited by 240
Self-citationMini-Review: Oxidative stress, redox stress or redox success?
Gutteridge, J. M. C., & Halliwell, B. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.045 · Cited by 227
Rafii, M. S., Tuszynski, M. H., Thomas, R. G., Barba, D., Brewer, J. B., Rissman, R. A., Siffert, J., Aisen, P. S., & for the AAV2-NGF Study Team (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0233 · Cited by 219
G‐quadruplex‐binding small molecules ameliorate C9orf72 FTD / ALS pathology in vitro and in vivo
Simone, R., Balendra, R., Moens, T. G., Preza, E., Wilson, K. M., Heslegrave, A., Woodling, N. S., Niccoli, T., Gilbert‐Jaramillo, J., Abdelkarim, S., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201707850 · Cited by 214
Lou, H., Jing, X., Wei, X., Shi, H., Ren, D., & Zhang, X. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.026 · Cited by 212
Reeve, A. K., Ludtmann, M. H., Angelova, P. R., Simcox, E. M., Horrocks, M. H., Klenerman, D., Gandhi, S., Turnbull, D. M., & Abramov, A. Y. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.166 · Cited by 198
Self-citationLoss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction
Kinghorn, K. J., Castillo-Quan, J. I., Bartolome, F., Angelova, P. R., Li, L., Pope, S., Cochemé, H. M., Khan, S., Asghari, S., Bhatia, K. P., et al. (2015) · Brain · doi:10.1093/brain/awv132 · Cited by 197
Self-citationGhofrani, S., Joghataei, M.-T., Mohseni, S., Baluchnejadmojarad, T., Bagheri, M., Khamse, S., & Roghani, M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.001 · Cited by 185
Ambrogini, P., Torquato, P., Bartolini, D., Albertini, M. C., Lattanzi, D., Di Palma, M., Marinelli, R., Betti, M., Minelli, A., Cuppini, R., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.01.026 · Cited by 185
Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia
Lynch, D. R., Farmer, J., Hauser, L., Blair, I. A., Wang, Q. Q., Mesaros, C., Snyder, N., Boesch, S., Chin, M., Delatycki, M. B., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.660 · Cited by 173
Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers
Peña‐Bautista, C., Baquero, M., Vento, M., & Cháfer‐Pericás, C. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.01.021 · Cited by 171
Koh, S.-H., Kim, S. H., Kwon, H., Park, Y., Kim, K. S., Song, C. W., Kim, J., Kim, M.-H., Yu, H.-J., Henkel, J. S., et al. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.07.003 · Cited by 169
Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich’s Ataxia Models
Abeti, R., Baccaro, A., Esteras, N., & Giunti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00188 · Cited by 165
Self-citationThe multiple faces of quercetin in neuroprotection
Ossola, B., Kääriäinen, T. M., & Männistö, P. T. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903026944 · Cited by 160
Pratt, D. A., Mills, J. H., & Porter, N. A. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034182j · Cited by 160
The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides
Abramov, A. Y., & Duchen, M. R. (2005) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1766 · Cited by 160
Self-citationEsteras, N., Dinkova-Kostova, A. T., & Abramov, A. Y. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0295 · Cited by 160
Self-citationNew Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases
Núñez, M. T., & Chaná‐Cuevas, P. (2018) · Pharmaceuticals · doi:10.3390/ph11040109 · Cited by 157
KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy
Shekh‐Ahmad, T., Eckel, R., Naidu, S. D., Higgins, M., Yamamoto, M. P., Dinkova‐Kostova, A. T., Kovac, S., Abramov, A. Y., & Walker, M. C. (2018) · Brain · doi:10.1093/brain/awy071 · Cited by 156
Self-citationLipid peroxidation is essential for α‐synuclein‐induced cell death
Angelova, P. R., Horrocks, M. H., Klenerman, D., Gandhi, S., Abramov, A. Y., & Shchepinov, M. S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13024 · Cited by 152
Self-citationChoi, J., Park, C., Kim, D.-J., Cho, M., Jin, B.-K., Pie, J.-E., & Chung, W. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00079-7 · Cited by 152
Khan, A., Ikram, M. A., Muhammad, T., Park, J., & Kim, M. O. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050680 · Cited by 142
Genoud, S., Roberts, B. R., Gunn, A. P., Halliday, G. M., Lewis, S. J. G., Ball, H. J., Hare, D. J., & Double, K. L. (2017) · Metallomics · doi:10.1039/c7mt00244k · Cited by 140
Iron chelation in the treatment of neurodegenerative diseases
Dušek, P., Schneider, S. A., & Aaseth, J. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.03.010 · Cited by 135
Vaarmann, A., Gandhi, S., & Abramov, A. Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.111450 · Cited by 134
Self-citationHan, J., Wang, M., Xu, J., Shi, H., Ren, M., & Lou, H. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1311-5 · Cited by 121
Chung, Y. C., Baek, J. Y., Kim, S. R., Ko, H. W., Bok, E., Shin, W.-H., Won, S.-Y., & Jin, B. K. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.159 · Cited by 121
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain
Hardas, S. S., Sultana, R., Clark, A. M., Beckett, T. L., Szweda, L. I., Murphy, M. P., & Butterfield, D. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.002 · Cited by 120
Esteras, N., Rohrer, J. D., Hardy, J., Wray, S., & Abramov, A. Y. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.008 · Cited by 120
Self-citationMitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation
Angelova, P. R., Barilani, M., Lovejoy, C. E. J., Dossena, M., Viganò, M., Seresini, A., Piga, D., Gandhi, S., Pezzoli, G., Abramov, A. Y., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.10.016 · Cited by 120
Self-citationLiu, M., Chen, F., Sha, L., Wang, S., Lin, T., Yao, L., He, M., Yao, Z., Liu, H., Zhu, Z., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8608-2 · Cited by 117
An Exceptionally Potent Inducer of Cytoprotective Enzymes
Dinkova‐Kostova, A. T., Talalay, P., Sharkey, J., Zhang, Y., Holtzclaw, W. D., Wang, X. J., David, E., Schiavoni, K. H., Finlayson, S. D., Mierke, D. F., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163485 · Cited by 107
Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage
Narayan, P. S., Holmström, K. M., Kim, D.-H., Whitcomb, D. J., Wilson, M. R., George‐Hyslop, P. S., Wood, N. W., Dobson, C. M., Cho, K., Abramov, A. Y., et al. (2014) · Biochemistry · doi:10.1021/bi401606f · Cited by 105
Self-citationPatra, S. K., Rizzi, F., Silva, A., Rugină, D. O., & Bettuzzi, S. (2008) · PubMed · Cited by 103
Huang, G., Chen, Y., Lu, H. K., & Cao, X. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402004 · Cited by 96
Köse, S. A., & Nazıroğlu, M. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1006214 · Cited by 95
Oteiza, P. I., Uchitel, O. D., Carrasquedo, F., Dubrovski, A. L., Roma, J. C., & Fraga, C. G. (1997) · Neurochemical Research · doi:10.1023/a:1027384432715 · Cited by 93
Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia
Zesiewicz, T. A., Heerinckx, F., Jager, R. D., Omidvar, O., Kilpatrick, M. W., Shaw, J., & Shchepinov, M. S. (2018) · Movement Disorders · doi:10.1002/mds.27353 · Cited by 93
Neurotrophin p75 Receptor Is Involved in Neuronal Damage by Prion Peptide-(106–126)
Bianca, V. D., Rossi, F., Armato, U., Prà, I. D., Costantini, C., Perini, G., Politi, V., & Valle, G. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107454200 · Cited by 92
Tu, J., Zhang, X., Zhu, Y., Dai, Y., Li, N., Yang, F., Zhang, Q., Brann, D. W., & Wang, R. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1304-15.2015 · Cited by 90
Raefsky, S. M., Furman, R., Milne, G., Pollock, E., Axelsen, P., Mattson, M. P., & Shchepinov, M. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.024 · Cited by 90
The spatiotemporal regulation of the Keap1–Nrf2 pathway and its importance in cellular bioenergetics
Dinkova‐Kostova, A. T., Baird, L., Holmström, K. M., Meyer, C. J., & Abramov, A. Y. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150003 · Cited by 87
Self-citationDopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
Gandhi, S., Vaarmann, A., Yao, Z., Duchen, M. R., Wood, N. W., & Abramov, A. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037564 · Cited by 82
Self-citationShchepinov, M. S., Chou, V., Pollock, E. D., Langston, J. W., Cantor, C. R., Molinari, R. J., & Manning-Bog, A. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.07.020 · Cited by 81
Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway
Richardson, B. G., Jain, A. D., Speltz, T. E., & Moore, T. W. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.019 · Cited by 80
Transition metal abnormalities in progressive dementias
Akatsu, H., Hori, A., Yamamoto, T., Yoshida, M., Mimuro, M., Hashizume, Y., Tooyama, I., & Yezdimer, E. M. (2011) · BioMetals · doi:10.1007/s10534-011-9504-8 · Cited by 79
Esteras, N., Kundel, F., Amodeo, G. F., Pavlov, E. V., Klenerman, D., & Abramov, A. Y. (2021) · The FEBS Journal · doi:10.1111/febs.15340 · Cited by 78 · cited 2×
“In almost all neurodegenerative diseases, ROS production and lipid peroxidation have been shown to be a hallmark of pathology, for example, FTD36,37 or ALS, where excessive levels of metabolites of lipid peroxidation have been found in the blood of patients.38 In tauopathy, activation of lipid peroxidation can be indu…”
BackgroundSelf-citationInteraction of neurons and astrocytes underlies the mechanism of Aβ-induced neurotoxicity
Angelova, P. R., & Abramov, A. Y. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140153 · Cited by 78
Self-citationIsotope-reinforced polyunsaturated fatty acids protect yeast cells from oxidative stress
Hill, S. A., Hirano, K., Shmanai, V. V., Marbois, B. N., Vidović, D., Bekish, A. V., Kay, B., Tse, V., Fine, J. A., Clarke, C. F., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.690 · Cited by 77
Aluminum in Neurological Disease - a 36 Year Multicenter Study
McLachlan, D. R. C., Alexandrov, P. N., Walsh, W. J., Pogue, A. I., Percy, M. E., Kruck, T. P. A., Fang, Z., Scharfman, N., Jaber, V. R., Zhao, Y., et al. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000457 · Cited by 72
Sharma, A., Pachauri, V., & Flora, S. J. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01247 · Cited by 69
Bartolomé, F. B., Esteras, N., Martín‐Requero, Á., Boutoleau‐Bretonnière, C., Vercelletto, M., Gabelle, A., Ber, I. L., Honda, T., Dinkova‐Kostova, A. T., Hardy, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01678-4 · Cited by 68
Self-citationSingh, S., & Kumar, P. (2016) · Pharmacology · doi:10.1159/000443896 · Cited by 65
Insights into the Potential Role of Mercury in Alzheimer’s Disease
Bjørklund, G., Tinkov, A. A., Dadar, M., Rahman, M. M., Chirumbolo, S., Skalny, A. V., Геннадиевна, С. М., Haley, B. E., Ajsuvakova, O. P., & Aaseth, J. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01274-3 · Cited by 64
Chelating Agents for Neurodegenerative Diseases
Ward, R. J., Dexter, D. T., & Crichton, R. R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800609689 · Cited by 63
Metcalfe, T., Bowen, D. M., & Muller, D. P. R. (1989) · Neurochemical Research · doi:10.1007/bf00965511 · Cited by 62
Lipid peroxidation is essential for phospholipase C activity and IP3 related calcium signal
Domijan, A., Kovac, S., & Abramov, A. Y. (2013) · Journal of Cell Science · doi:10.1242/jcs.138370 · Cited by 57
Self-citationNaringenin targets on astroglial Nrf2 to support dopaminergic neurons
Wang, G., Zhang, B., He, X., Li, D., Shi, J., & Zhang, F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.043 · Cited by 55
Abbey, E. L., & Rankin, J. W. (2011) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.21.2.91 · Cited by 54
Hatami, A., Zhu, C., Relaño-Ginés, A., Elias, C. J., Galstyan, A., Jun, M., Milne, G. L., Cantor, C. R., Chesselet, M., & Shchepinov, M. S. (2018) · FEBS Journal · doi:10.1111/febs.14590 · Cited by 54
Martínez, A., Carmona, M., Portero‐Otín, M., Naudí, A., Pamplona, R., & Ferrer, I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e06f3 · Cited by 53
Lee, H., Baek, S., Chun, S. Y., Lee, J., & Cho, H. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.11.035 · Cited by 52
Zn2+ Aggravates Tau Aggregation and Neurotoxicity
Li, X., Du, X., & Ni, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030487 · Cited by 51
Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism
Tadolini, B., & Franconi, F. (1998) · Free Radical Research · doi:10.1080/10715769800300421 · Cited by 50
Human GAPDH Is a Target of Aspirin’s Primary Metabolite Salicylic Acid and Its Derivatives
Choi, H. W., Tian, M., Manohar, M., Harraz, M. M., Park, S. W., Schroeder, F. C., Snyder, S. H., & Klessig, D. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143447 · Cited by 50
Angelova, P. R., & Müller, W. S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04767.x · Cited by 49
Self-citationArber, C., Angelova, P. R., Wiethoff, S., Tsuchiya, Y., Mazzacuva, F., Preza, E., Bhatia, K. P., Mills, K. A., Gout, I. T., Abramov, A. Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184104 · Cited by 49
Self-citationYoudim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1990) · Springer eBooks · doi:10.1007/978-3-7091-9113-2_34 · Cited by 44
Cellular mechanisms of complex I-associated pathology
Abramov, A. Y., & Angelova, P. R. (2019) · Biochemical Society Transactions · doi:10.1042/bst20191042 · Cited by 44
Self-citationRNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.055 · Cited by 43
Multiple pathways for natural product treatment of Parkinson's disease: A mini review
Li, J., Long, X., Hu, J., Bi, J., Zhou, T., Guo, X., Han, C., Huang, J., Wang, T., Xiong, N., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152954 · Cited by 42
de Araújo, D. P., de Sousa, C. N. S., Araújo, P. V. P., Menezes, C. E. D. S., Rodrigues, F. T. S., Escudeiro, S. D. S., Lima, N. B. C., Patrocínio, M. C. A., Aguiar, L. M. V., Viana, G. S. D. B., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/571378 · Cited by 39
Krishnan, G., Zhang, Y., Gu, Y., Kankel, M. W., Gao, F., & Almeida, S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02154-6 · Cited by 38
Free radicals and mitochondrial dysfunction in Parkinson's disease
Schapira, A. H. V., Hartley, A., Cleeter, M. W. J., et al. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210367 · Cited by 37
Al‐Menhali, A. S., Banu, S., Angelova, P. R., Barcaru, A., Horvatovich, P. L., Abramov, A. Y., & Jaganjac, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.129487 · Cited by 36
Self-citationAngelova, P. R., & Müller, W. S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06737.x · Cited by 33
Self-citationA pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
Rohani, M., Razmeh, S., Shahidi, G. A., & Orooji, M. (2018) · Neurology International · doi:10.4081/ni.2017.7279 · Cited by 27
Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing
Artyukhova, M. A., Tyurina, Y. Y., Chu, C. T., Zharikova, T. M., Bayır, H., Kagan, V. E., & Timashev, P. S. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.007 · Cited by 27
Nogueira, C. R., Borges, F. T., Lameu, E. B., Franca, C. A. D. S., & Ramalho, A. (2013) · PubMed · doi:10.3305/nh.2013.28.5.6590 · Cited by 26
Naringenin Ameliorates Drosophila ReepA Hereditary Spastic Paraplegia-Linked Phenotypes
Napoli, B., Gumeni, S., Forgiarini, A., Fantin, M., Filippis, C. D., Panzeri, E., Vantaggiato, C., & Orso, G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01202 · Cited by 26
Alcalde, L. A., de Freitas, B. S., Machado, G. D. B., Crivelaro, P. C. D. F., Dornelles, V. C., Gus, H., Monteiro, R. T., Kist, L. W., Bogo, M. R., & Schröder, N. (2018) · BioMetals · doi:10.1007/s10534-018-0135-1 · Cited by 25
Sethi, S. K., Kisch, S. J., Ghassaban, K., Rajput, A. H., Rajput, A. H., Babyn, P., Liu, S., Szkup, P., & Haacke, E. M. (2018) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2018.10.001 · Cited by 21
Copper and zinc ions govern the trans‐directed dimerization of APP family members in multiple ways
August, A., Schmidt, N., Klingler, J., Baumkötter, F., Lechner, M., Klement, J., Eggert, S., Vargas, C., Wild, K., Keller, S., et al. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14716 · Cited by 19
Reversal of Experimental Ethanol‐induced Liver Steatosis by Borage Oil
Lukivskaya, O., Naruta, E. E., Sadovnichy, V. V., Kirko, S. N., & Buko, V. U. (2012) · Phytotherapy Research · doi:10.1002/ptr.4621 · Cited by 13
Cited by
RONS and Oxidative Stress: An Overview of Basic Concepts
Aranda-Rivera, A. K., Cruz-Gregorio, A., Arancibia-Hernández, Y. L., Hernández-Cruz, E. Y., & Pedraza-Chaverri, J. (2022) · Oxygen · doi:10.3390/oxygen2040030 · Cited by 384
Lipid Peroxidation and Antioxidant Protection
Valgimigli, L. (2023) · Biomolecules · doi:10.3390/biom13091291 · Cited by 335
Interaction of Mitochondrial Calcium and ROS in Neurodegeneration
Baev, A. Y., Vinokurov, A. Y., Novikova, I. N., Dremin, V. V., Potapova, E. V., & Abramov, A. Y. (2022) · Cells · doi:10.3390/cells11040706 · Cited by 162
Self-citationNew hope for Parkinson’s disease treatment: Targeting gut microbiota
Fan, H., Sheng, S., & Zhang, F. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13916 · Cited by 66
Wei, M., Bao, G., Li, S., Yang, Z., Cheng, C., & Le, W. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114333 · Cited by 55
Metadata
- Authors
- Angelova, P. R., Esteras, N., & Abramov, A. Y.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2020-07-13
- Volume
- 41
- Issue
- 2
- Pages
- 770-784
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W3043203703
- Cited by
- 287
- References
- 138
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.